Multiple defects in counterregulation of hypoglycemia in modestly advanced type 2 diabetes mellitus

Metabolism: Clinical and Experimental
Zarmen IsraelianChristian Meyer

Abstract

In type 2 diabetes mellitus (T2DM), little is known about hormonal responses to hypoglycemia. In particular, beta-cell responses to hypoglycemia have not been carefully investigated and potentially because of confounding factors or insufficient power, conflicting data have been obtained regarding growth hormone responses. We therefore compared hormonal responses including rates of insulin secretion during a 2-hour hyperinsulinemic hypoglycemic clamp in a relatively large number of nondiabetic (n=21) and moderately insulin-deficient subjects with T2DM (homeostasis model assessment of beta-cell function [HOMA-%B], 751+/-160 vs 1144+/-83 [pmol/L]/[mmol/L], P<.04) (n=14) matched for age, sex, and body mass index. Subjects with T2DM were excluded for antecedent hypoglycemia, and baseline glycemia was controlled by a variable infusion of insulin overnight. Although both groups of subjects had indistinguishable plasma glucose levels at baseline and virtually identical levels of plasma insulin and glucose throughout the hypoglycemic clamp, insulin secretion decreased more slowly in the subjects with T2DM. The time required for insulin secretion to decline to half its baseline level was markedly increased (38.9+/-4.9 vs 22.3+/-1.3 minut...Continue Reading

References

Jun 1, 1979·Diabetologia·L V CampbellL Lazarus
Nov 1, 1991·The Journal of Clinical Endocrinology and Metabolism·M R Davis, H Shamoon
Oct 1, 1987·The Journal of Clinical Endocrinology and Metabolism·F F CasanuevaA Fernandez-Cruz
Sep 1, 1980·The Journal of Clinical Endocrinology and Metabolism·R P EatonJ Standefer
Jun 1, 1981·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·F CasanuevaJ Cabezas-Cerrato
Jul 1, 1980·Circulation Research·S WallensteinJ L Fleiss
Jul 1, 1994·Diabetes/metabolism Reviews·R Hovorka, R H Jones
Feb 1, 1994·Metabolism: Clinical and Experimental·M MaccarioE Ghigo
Mar 2, 2002·Diabetes·Scott A SegelPhilip E Cryer
May 27, 2003·Diabetes Care·Philip E CryerHarry Shamoon
Oct 28, 2003·Diabetes Care·Saul GenuthUNKNOWN Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
May 27, 2004·Diabetes Care·Tara M WallaceDavid R Matthews

❮ Previous
Next ❯

Citations

Sep 10, 2008·Current Diabetes Reports·Christopher T Kodl, Elizabeth R Seaquist
Dec 1, 2011·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Sylvie Dejager, Anja Schweizer
Jun 7, 2012·American Journal of Physiology. Endocrinology and Metabolism·Daniel M KeenanJohannes D Veldhuis
Jan 7, 2014·Vascular Health and Risk Management·Anja SchweizerSylvie Dejager
Jul 4, 2009·Diabetic Medicine : a Journal of the British Diabetic Association·P ChoudharyS R Heller
Nov 3, 2010·Annals of the New York Academy of Sciences·Nolawit Tesfaye, Elizabeth R Seaquist
Apr 14, 2016·Scientific Reports·Guillaume OsterstockPierre-François Méry
Jul 30, 2009·Diabetes Care·Stephanie A Amiel
Apr 20, 2018·Diabetes·Nina Xiaoyan LiDavid E Kelley
Mar 30, 2018·Frontiers in Physiology·Chunxue ZhouVanessa H Routh
Oct 18, 2007·Current Opinion in Endocrinology, Diabetes, and Obesity
Oct 18, 2007·Current Opinion in Endocrinology, Diabetes, and Obesity

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.